PSYLLIUM/DOCUSATE SALTS INCLUSION IN LAXATIVE MONOGRAPH URGED
This article was originally published in The Tan Sheet
Executive Summary
PSYLLIUM/DOCUSATE SALTS INCLUSION IN LAXATIVE MONOGRAPH URGED by Procter & Gamble in a Dec. 28 letter to FDA. P&G requested that the agency permit docusate sodium/psyllium and docusate calcium/psyllium as Category I (safe and effective) combinations under the OTC laxative products monograph. In a September 1993 notice of proposed rulemaking to amend the laxative tentative final monograph, FDA concluded that oral dosage forms of docusate sodium and docusate calcium and rectal enema dosage forms of docusate potassium are Category I as stool-softener laxative ingredients ("The Tan Sheet" Sept. 6, 1993, p. 5). P&G markets the psyllium-based laxative Metamucil.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC